Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica
Neuromyelitis optica (NMO) is an autoimmune disease in which a specific biomarker named NMO-IgG and directed against aquaporin-4 (AQP4) has been found. A correlation between disease activity and anti-AQP4 antibody (Ab) serum concentration or complement-mediated cytotoxicity has been reported, but th...
Saved in:
Main Authors: | Jean-Baptiste Chanson, Melissa Alame, Nicolas Collongues, Frédéric Blanc, Marie Fleury, Gabrielle Rudolf, Jérôme de Seze, Thierry Vincent |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/146219 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical characteristics of anti-myelin oligodendrocyte glycoprotein antibody among aquaporin-4 negative neuromyelitis optica spectrum disorders in Egyptian patients
by: Sara I. Taha, et al.
Published: (2025-01-01) -
Neuromyelitis optica spectrum disorder: epidemiology, pathogenesis, diagnosis, treatment, and prognosis
by: J. Čemerkaitė, et al.
Published: (2021-03-01) -
Acute Respiratory Failure due to Neuromyelitis Optica Treated Successfully with Plasmapheresis
by: Massa Zantah, et al.
Published: (2016-01-01) -
The Big Yawning: Pathological Yawning as a Symptom of Neuromyelitis Optica Spectrum Disorders
by: Veronika Spahlinger, et al.
Published: (2019-01-01) -
Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering
by: Ryohei Yamamura, et al.
Published: (2025-02-01)